Status
Conditions
About
Study objectives:
Full description
There are 2 clinically important and urgent questions to be explored in this study: 1. Who is more likely to benefit from guided drug reduction or discontinuation? How to design an individualized treatment plan which can balance the risk of relapse and side-effects from antipsychotics? 2. What are the predictors of functional remission in patients with schizophrenia after drug discontinuation? This will be the first related study to be conducted in China.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
480 participants in 4 patient groups
Loading...
Central trial contact
Dengtang Liu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal